Table 6

Co-expression of ER/PGR and their prediction for disease-specific survival in patients with soft tissue sarcomas (univariate analysis; log-rank test)
Co-expression Patients (n) Patients (%) Median survival (months) 5-year survival (%) P
ER / PGR, all, N = 193
Low/low 84 44 NR 69 <0.001
Low/high 26 13 38 24
High/low 41 21 62 52
High/high 31 16 NR 64
Missing 11 6
ER / PGR, men, N = 81
Low/low 39 48 NR 79 0.013
Low/high 9 11 41 33
High/low 23 28 63 53
High/high 6 7 37 33
Missing 4 5
ER / PGR, women, N = 121
Low/low 45 40 89 59 0.001
Low/high 17 15 31 19
High/low 18 16 29 50
High/high 25 22 NR 72
Missing 7 6
ER / PGR, <60 years, N = 99
Low/low 41 41 NR 72 0.001
Low/high 13 13 31 23
High/low 19 19 NR 58
High/high 21 21 NR 76
Missing 5 5
ER / PGR, ≥60 years, N = 94
Low/low 43 46 NR 64 0.052
Low/high 13 14 39 26
High/low 22 23 58 47
High/high 10 11 37 40
Missing 6 6
ER / PGR, Skp2 low, N = 109
Low/low 55 50 NR 76 0.068
Low/high 9 8 68 25
High/low 23 21 91 61
High/high 16 15 75 56
Missing 6 6
ER / PGR, Skp2 high, N = 67
Low/low 21 31 89 55 0.005
Low/high 14 21 31 29
High/low 17 25 29 42
High/high 13 19 NR 77
Missing 2 3

Abbreviations: NR, not reached.

Sorbye et al.

Sorbye et al. BMC Clinical Pathology 2013 13:9   doi:10.1186/1472-6890-13-9

Open Data